Stryker Corporation (SYK)
NYSE: SYK · Real-Time Price · USD
310.73
-2.35 (-0.75%)
Nov 20, 2026, 3:49 PM EST - Market open
Stryker Revenue
Stryker had revenue of $6.52B in the quarter ending September 30, 2026, with 7.64% growth. This brings the company's total for the last twelve months to $26.30B, up 7.87% year-over-year. In the year 2025, Stryker had annual revenue of $25.12B with 11.16% growth. That makes Stryker the 553rd largest company in the world by revenue and 193rd in the United States.
Revenue (ttm)
$26.30B
Revenue Growth
+7.87%
P/S Ratio
4.58
Revenue / Employee
$469,643
Employees
56,000
Market Cap
118.29B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Stryker breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 25.12B | 2.52B | 11.16% |
| Dec 31, 2024 | 22.60B | 2.10B | 10.23% |
| Dec 31, 2023 | 20.50B | 2.05B | 11.11% |
| Dec 31, 2022 | 18.45B | 1.34B | 7.84% |
| Dec 31, 2021 | 17.11B | 2.76B | 19.21% |
| Dec 31, 2020 | 14.35B | -533.00M | -3.58% |
| Dec 31, 2019 | 14.88B | 1.28B | 9.43% |
| Dec 31, 2018 | 13.60B | 1.16B | 9.30% |
| Dec 31, 2017 | 12.44B | 1.12B | 9.88% |
| Dec 31, 2016 | 11.33B | 1.38B | 13.86% |
| Dec 31, 2015 | 9.95B | 271.00M | 2.80% |
| Dec 31, 2014 | 9.68B | 654.00M | 7.25% |
| Dec 31, 2013 | 9.02B | 364.00M | 4.20% |
| Dec 31, 2012 | 8.66B | 350.00M | 4.21% |
| Dec 31, 2011 | 8.31B | 987.00M | 13.48% |
| Dec 31, 2010 | 7.32B | 597.00M | 8.88% |
| Dec 31, 2009 | 6.72B | 4.80M | 0.07% |
| Dec 31, 2008 | 6.72B | 717.70M | 11.96% |
| Dec 31, 2007 | 6.00B | 853.30M | 16.58% |
| Dec 31, 2006 | 5.15B | 538.30M | 11.68% |
| Dec 31, 2005 | 4.61B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories | 48.23B |
| Medtronic | 37.54B |
| GE HealthCare Technologies | 21.64B |
| Boston Scientific | 21.07B |
| Koninklijke Philips | 20.16B |
| Zimmer Biomet Holdings | 8.57B |
| Edwards Lifesciences | 6.67B |
| STERIS | 6.17B |
SYK News
- 1 day ago - Stryker price target raised to $356 from $340 at Leerink - TheFly
- 2 days ago - Stryker price target raised to $345 from $304 at BTIG - TheFly
- 3 days ago - Stryker Transcript: Jefferies Global Healthcare Conference - Transcripts
- 10 days ago - Stryker nominates Quest Diagnostics CEO Jim Davis to board - TheFly
- 10 days ago - Stryker announces intention to nominate Jim Davis to board of directors - GlobeNewsWire
- 11 days ago - Stryker price target raised to $350 from $325 at Piper Sandler - TheFly
- 15 days ago - Stryker files automatic mixed securities shelf - TheFly
- 18 days ago - Stryker price target lowered to $305 from $310 at Truist - TheFly